Frontiers in Cellular and Infection Microbiology
Scope & Guideline
Empowering science through open access innovation.
Introduction
Aims and Scopes
- Infection Biology and Pathogenesis:
Research on the mechanisms of infection by various pathogens, including bacteria, viruses, fungi, and parasites. Studies often focus on understanding how these microorganisms exploit host cellular processes to establish infections. - Host-Microbe Interactions:
Investigations into how the host immune system interacts with pathogens and commensal organisms, including the role of the gut microbiome in health and disease. - Antimicrobial Resistance and Novel Therapeutics:
Research aimed at understanding the mechanisms of antimicrobial resistance and the development of new therapeutic strategies, including the use of phage therapy, probiotics, and novel drug compounds. - Microbial Genomics and Metagenomics:
Utilization of advanced genomic techniques to analyze microbial communities, pathogen genomes, and their implications for disease diagnosis and treatment. - Clinical Microbiology and Diagnostics:
Application of innovative diagnostic tools, including metagenomic next-generation sequencing, to improve pathogen detection and patient outcomes in infectious diseases. - Translational Research:
Focus on bridging laboratory research with clinical applications, including the development of vaccines and therapeutic interventions based on microbiome research.
Trending and Emerging
- Gut Microbiota and Health:
Research focusing on the gut microbiome and its implications for various diseases, including metabolic disorders, autoimmune diseases, and infections, has surged. This reflects a growing recognition of the microbiome's role in overall health. - COVID-19 Research:
There has been an explosive increase in studies related to SARS-CoV-2, encompassing various aspects such as pathogenesis, immune response, diagnostics, and long-term effects, as the pandemic continues to influence global health. - Antimicrobial Resistance Mechanisms:
A growing body of research is dedicated to elucidating the mechanisms behind antimicrobial resistance, including the genetic and phenotypic characteristics of resistant strains, which is crucial for developing new treatment strategies. - Phage Therapy and Novel Antimicrobials:
Interest in bacteriophage therapy and other novel antimicrobial agents has increased as potential alternatives to traditional antibiotics, particularly in the context of rising antimicrobial resistance. - Infection Control and Prevention Strategies:
Studies focusing on innovative infection control measures, including the use of probiotics, dietary interventions, and environmental factors affecting microbial infection rates, are trending.
Declining or Waning
- Traditional Culture-Based Microbiology:
There has been a noticeable decline in publications focusing solely on traditional culture-based methods for microbial identification and susceptibility testing, as newer techniques such as metagenomics gain prominence. - Basic Virology Studies:
Research papers dedicated to basic virology without a clear link to clinical implications or translational applications have become less frequent, as the focus shifts towards understanding viral pathogenesis and therapeutic strategies. - Historical Epidemiological Studies:
There appears to be a reduction in the publication of historical epidemiological studies that do not incorporate modern analytical techniques or tools, as more researchers seek to apply contemporary methods to solve current health issues. - Studies on Non-Pathogenic Microbes:
The exploration of non-pathogenic microbes and their roles in human health has decreased, with more emphasis placed on pathogenic microbes and their interactions with the immune system.
Similar Journals
TRENDS IN MICROBIOLOGY
Advancing the Frontiers of Microbial ScienceTRENDS IN MICROBIOLOGY is a premier academic journal published by CELL PRESS, renowned for its high-impact research contributions in the fields of microbiology, infectious diseases, medical microbiology, and virology. With an impressive impact factor and a notable Scopus ranking—placing it in the top tiers of its categories, including a remarkable Q1 status in multiple disciplines—this journal is essential for researchers, professionals, and students aiming to stay at the forefront of innovative microbial research and ongoing advancements in pathogen biology. Since its inception in 1993, TRENDS IN MICROBIOLOGY has provided a platform for thought-provoking reviews and critical insights, fostering discussions that shape the future of the microbiological sciences. Based in the United Kingdom, TRENDS IN MICROBIOLOGY continues to lead the way in disseminating vital knowledge within the global scientific community.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY
Driving innovation in the study of microbes and their immune interactions.Medical Microbiology and Immunology is a renowned journal published by Springer, serving as a pivotal resource in the fields of microbiology and immunology. Established in 1971 and continuing its legacy through 2024, this journal features cutting-edge research and reviews that address critical advancements and challenges within these dynamic fields. With an impressive impact factor and a robust ranking, including Q1 categories in both Microbiology (medical) and Immunology, it stands at the forefront of scholarly communication, ranking 21st out of 140 in the realm of Medical Microbiology. Researchers and professionals are encouraged to explore a variety of studies that delve into the interactions between microorganisms and the immune system, making it an essential resource for anyone fascinated by these interconnected realms of health sciences. Although not open access, the journal is widely accessible through institutional libraries, ensuring that significant findings reach a global audience. The University of New York Plaza serves as its operational hub in the USA, reinforcing its international influence and dedication to advancing knowledge in microbiology and immunology.
Mediterranean Journal of Infection Microbes and Antimicrobials
Elevating research on infectious diseases and antimicrobials.Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.
Microbiology Research
Pioneering Discoveries in Microbial ResearchMicrobiology Research, published by MDPI, stands as a pivotal open-access journal in the field of microbiology, having established its presence since 2010. Based in Switzerland, this journal strives to provide a platform for innovative research and cutting-edge findings in various branches of microbiology, including medical microbiology and molecular biology. With an impact factor that reflects its dedication to scholarly excellence, Microbiology Research is classified in the Q3 category for both microbiology and medical microbiology, and Q4 for molecular biology as of 2023, indicating its growing importance and outreach within these domains. The journal aims to foster discussion and collaboration among researchers, professionals, and students by presenting articles that cover a wide array of topics and methodologies in microbiological research. Leveraging its open-access model, Microbiology Research ensures that high-quality research is accessible to a global audience, thus facilitating the advancement of knowledge and innovation in the microbial sciences.
CELLULAR MICROBIOLOGY
Pioneering Research in Cellular MicrobiologyCELLULAR MICROBIOLOGY, published by Wiley-Hindawi, is a prominent journal in the fields of Immunology, Microbiology, and Virology. With its ISSN 1462-5814 and E-ISSN 1462-5822, this journal serves as a vital platform for researchers to disseminate their findings and contribute to the growing body of knowledge surrounding cellular interactions and microbial processes. Operating from the United Kingdom, CELLULAR MICROBIOLOGY has distinguished itself by ranking in the top quartile of Microbiology (Q1) and maintaining a solid Q2 status in both Immunology and Virology as of 2023. The journal has also demonstrated excellent performance in Scopus rankings, boasting significant percentiles in its respective categories. Although primarily subscription-based, the journal aims to continuously advance the understanding of cellular microbiology through rigorous peer-reviewed research spanning from 1999 to 2024. Researchers, professionals, and students alike will find this journal an invaluable resource for the latest scientific breakthroughs and theoretical advancements in the microbiological and immunological realms.
FEMS MICROBIOLOGY REVIEWS
Championing High-Impact Reviews in MicrobiologyFEMS Microbiology Reviews, published by Oxford University Press, is a leading journal in the field of microbiology, with a notable impact in related disciplines such as infectious diseases and medicine. Since its inception in 1989, this esteemed journal has grown to occupy a prestigious position, consistently ranking in the first quartile (Q1) in various categories, including Infectious Diseases, Medicine (miscellaneous), and Microbiology. With an impressive Scopus ranking of #13 in Microbiology and #25 in Infectious Diseases, it is recognized for its high-quality and impactful reviews that bridge the gap between fundamental microbiological research and practical applications. Aimed at researchers, professionals, and students alike, FEMS Microbiology Reviews offers critical insights and comprehensive analyses, making it an essential resource for those engaged in the dynamic study of microbial life and its implications for health and disease.
CLINICAL MICROBIOLOGY AND INFECTION
Exploring Innovations in MicrobiologyCLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.
MICROBIAL PATHOGENESIS
Advancing the Science of Microbial InfectionsMICROBIAL PATHOGENESIS, published by Academic Press Ltd - Elsevier Science Ltd, is a prominent journal in the fields of Infectious Diseases and Microbiology, with a notable impact factor and classified in the Q2 quartile for both categories as of 2023. Since its inception in 1986, this journal has provided a platform for the dissemination of cutting-edge research that enhances our understanding of microbial infections and their implications in health and disease. The journal is indexed in Scopus, ranking #80 among 344 in Infectious Diseases and #57 among 182 in Microbiology, underscoring its significant contribution to the scientific community. Although it operates under a traditional subscription model, the content is vital for researchers, professionals, and students focused on the dynamics of microbial pathogenesis and the development of innovative therapeutic strategies. The journal's comprehensive scope aims to foster advancements in this critical area of study, bridging the gap between laboratory research and clinical applications.
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA
Shaping the future of microbiological inquiry.ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA is a distinguished academic journal published by AKADEMIAI KIADO ZRT, focusing on significant advancements in the fields of microbiology, immunology, and infectious diseases. Established in 1994, this journal serves as a vital platform for researchers, professionals, and students keen on exploring the complexities of microbial interactions and immune responses. With a current Impact Factor reflecting its rank within the Q3 categories for Immunology, Microbiology, and Infectious Diseases, it retains a critical position in disseminating innovative research. Although not open access, the journal provides extensive insights disseminated through various academic databases, ensuring a broad reach within the scholarly community. Its convergence over three decades indicates a robust commitment to excellence in scientific inquiry and knowledge sharing. As it moves towards the future, ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA continues to uphold its legacy of fostering collaborative research initiatives that contribute to the understanding and treatment of microbial diseases globally.
Nature Microbiology
Unveiling the Secrets of Microbial LifeNature Microbiology is a premier journal published by NATURE PORTFOLIO that has firmly established itself within the realms of microbiological research since its inception in 2016. Based in the United Kingdom, this prestigious journal specializes in the intricacies of applied microbiology, cell biology, genetics, immunology, and medical microbiology, making it a cornerstone for academics and professionals alike. With an impressive Scopus ranking placing it in the top tier across various relevant categories—such as rank #3 in Genetics and #2 in Applied Microbiology—it underscores the journal’s commitment to high-quality, impactful research. Although it operates under a subscription model, Nature Microbiology's broad Open Access policy facilitates greater dissemination and visibility for its authors. The journal's objectives are centered around publishing cutting-edge advancements that enhance our understanding of microbial life, its interactions, and applications in health and disease. As a Q1 journal across multiple disciplines, it holds immense significance for researchers, professionals, and students enthusiastic about the latest innovations and breakthroughs in microbiology.